Related references
Note: Only part of the references are listed.Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults
Pauline Byakika-Kibwika et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development
Sophie Zaloumis et al.
MALARIA JOURNAL (2012)
PfCRT and its role in antimalarial drug resistance
Andrea Ecker et al.
TRENDS IN PARASITOLOGY (2012)
The Activities of Current Antimalarial Drugs on the Life Cycle Stages of Plasmodium: A Comparative Study with Human and Rodent Parasites
Michael Delves et al.
PLOS MEDICINE (2012)
Development, Evaluation, and Application of an In Silico Model for Antimalarial Drug Treatment and Failure
Katherine Winter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
The Threat of Artemisinin-Resistant Malaria
Arjen M. Dondorp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Intrahost modeling of artemisinin resistance in Plasmodium falciparum
Sompob Saralamba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
How artemisinin-containing combination therapies slow the spread of antimalarial drug resistance
Ian Hastings
TRENDS IN PARASITOLOGY (2011)
Artemisinin Resistance in Cambodia: A Clinical Trial Designed to Address an Emerging Problem in Southeast Asia
Harald Noedl et al.
CLINICAL INFECTIOUS DISEASES (2010)
High Heritability of Malaria Parasite Clearance Rate Indicates a Genetic Basis for Artemisinin Resistance in Western Cambodia
Tim J. C. Anderson et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Factors contributing to delay in parasite clearance in uncomplicated falciparum malaria in children
Akintunde Sowunmi et al.
MALARIA JOURNAL (2010)
Plasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugs
Jianbing Mu et al.
NATURE GENETICS (2010)
Artemisinin resistance: current status and scenarios for containment (vol 8, pg 272, 2010)
Arjen M. Dondorp et al.
NATURE REVIEWS MICROBIOLOGY (2010)
Malaria's Drug Miracle in Danger
Martin Enserink
SCIENCE (2010)
Artemisinin resistance could endanger fight against malaria
Talha Burki
LANCET INFECTIOUS DISEASES (2009)
Towards optimal design of anti-malarial pharmacokinetic studies
Julie A. Simpson et al.
MALARIA JOURNAL (2009)
Artemisinin Resistance in Plasmodium falciparum Malaria.
Arjen M. Dondorp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Changes in the Treatment Responses to Artesunate-Mefloquine on the Northwestern Border of Thailand during 13 Years of Continuous Deployment
Verena Ilona Carrara et al.
PLOS ONE (2009)
The time course of drug effects
Hesham S. Al-Sallami et al.
PHARMACEUTICAL STATISTICS (2009)
Pharmacokinetic determinants of the window of selection for antimalarial drug resistance
K. Stepniewska et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Evidence of Artemisinin-Resistant Malaria in Western Cambodia
Harald Noedl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border
Chansuda Wongsrichanalai et al.
EMERGING INFECTIOUS DISEASES (2008)
Mechanism-based pharmacokinetic-pharmacodynamic modeling of antimicrobial drug effects
David Czock et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2007)
Tolerance is the key to understanding antimalarial drug resistance
IM Hastings et al.
TRENDS IN PARASITOLOGY (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Evolution of resistance to sulfadoxine-pyrimethamine in Plasmodium falciparum
ML Gatton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
The evolution of drug-resistant malaria: the role of drug elimination half-life
IM Hastings et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES (2002)
Pharmacokinetic-pharmacodynamic modelling of the antimalarial activity of mefloquine
MB Hoshen et al.
PARASITOLOGY (2001)
Mefloquine pharmacokinetic-pharmacodynamic models: Implications for dosing and resistance
JA Simpson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine
A Brockman et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2000)
Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria
P Newton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Mathematical modelling of the chemotherapy of Plasmodium falciparum malaria with artesunate: postulation of 'dormancy', a partial cytostatic effect of the drug, and its implication for treatment regimens
MB Hoshen et al.
PARASITOLOGY (2000)
Share Paper
